Search results
5 FDA decisions to watch in the third quarter
BioPharma Dive· 2 days agoMultibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...
Sirnaomics concludes Phase I trial of pancreatic cancer treatment
Clinical Trials Arena· 5 days agoIt was designed to assess the safety, tolerability, and anti-tumour activity of STP707, using...
EAN 2024: The role of B cells in shaping rituximab use in generalised MG
Clinical Trials Arena· 11 hours agoKey opinion leaders (KOLs) previously interviewed by leading data and analytics company GlobalData...
Rare and fatal brain-eating amoeba infection | Explained
The Hindu· 1 day agoA12-year-old boy, E.P. Mridul, from Feroke in Kozhikode district of Kerala, who had been undergoing ...
FDA approves a second Alzheimer's drug that can modestly slow disease - CNBC TV18
CNBC TV18· 2 days agoU.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing...
The state of oligonucleotide therapeutic manufacturing: what biopharmaceutical players need to know
Pharmaceutical Technology· 4 days agoIn the genomic medicine toolbox, oligonucleotide therapeutics offer highly specific and effective ...
Healthy at Every Size? Here's What Doctors Look for Beyond BMI
Verywell Health· 2 days agoPeople with chronic diseases, in particular, shouldn't place too much importance on BMI, Gitomer...
Microbot secures second site for Liberty endovascular robot trial
Clinical Trials Arena· 9 hours agoThe study included a microscopic evaluation of target vessels and surrounding tissues after using...
Horoscope Today: Astrological prediction for July 6, 2024
Hindustan Times· 2 hours agoDaily horoscope: Are the stars lined up in your favour? Find out the astrological prediction for...
New gene editing tool to cure rare disorders | Hyderabad News - Times of India
The Times of India· 3 days agoand Industrial Research - Institute of Genomics and Integrative Biology (CSIR-IGIB) in New Delhi and the LV Prasad Eye Institute (LVPEI ...